GRS News

At Global Regulatory Services (GRS), we’re proud to share that our experts, Greer Deal and Tracey Goldsworthy, have published a comprehensive article in TOPRA's Regulatory Rapporteur titled "Introduction to Cannabinoids: Understanding UK Regulation, Structure, Industry Dynamics, and Charting the Future."

This insightful piece delves deep into the evolving landscape of CBD in the UK, exploring the regulatory framework, medicinal uses, and the opportunities and challenges facing the industry. With cannabis-derived products gaining prominence for their potential in wellness and medicinal applications, navigating the complex regulatory pathways is crucial for companies aiming to succeed in this space. Greer and Tracey’s article provides a valuable overview of the regulatory mechanisms at play and highlights how UK regulations are shaping the future of cannabinoids.

Access the Article: TOPRA members can read the full article by clicking here. Non-members can request a copy by emailing grs@globalregulatoryservices.com

How GRS Can Help Medicinal CBD Companies Thrive:

As regulatory challenges continue to evolve, GRS is at the forefront, helping CBD companies ensure compliance with UK regulations while streamlining their journey through Regulatory Affairs and Quality Assurance (RAQA) processes. Whether you’re seeking assistance with market authorisation, compliance with the Misuse of Drugs Act, or navigating the novel food regulations for CBD products, our experienced team is here to guide you through every step.

With years of expertise, GRS offers tailored support to help your business meet its objectives while staying compliant in an ever-changing landscape. From product development to regulatory submissions, we work hand in hand with companies to ensure they’re fully prepared for the UK market.

Contact Us Today: Contact us to discover how we can support your CBD business in achieving regulatory compliance and market success! To start a conversation, email us at grs@globalregulatoryservices.com